VANGUARD REPROCESSED COMPRESSION GARMENT

K012403 · Vanguard Medical Concepts, Inc. · JOW · Oct 17, 2001 · Cardiovascular

Device Facts

Record IDK012403
Device NameVANGUARD REPROCESSED COMPRESSION GARMENT
ApplicantVanguard Medical Concepts, Inc.
Product CodeJOW · Cardiovascular
Decision DateOct 17, 2001
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.5800
Device ClassClass 2
AttributesTherapeutic

Intended Use

When coupled with an appropriate inflation system, compression garments are intended to increase venous return from the legs and feet as a prophylaxis for the formation of deep vein thrombosis (DVT) or subsequent pulmonary embolism (PE) in high risk and/or non-ambulatory patients. The compression garments are prescription devices intended for a single patient use only.

Device Story

Reprocessed compression garments; used with external air compression pump; pump inflates garment bladders to apply pressure to patient extremities; prevents blood pooling; increases venous flow. Used in clinical settings; operated by healthcare staff. Vanguard Medical Concepts collects used OEM garments; cleans, inspects, tests, repackages, and sterilizes via ethylene oxide; returns to facility. Output is mechanical compression; aids DVT/PE prophylaxis.

Clinical Evidence

Bench testing only. Validation included decontamination, cleaning, packaging, and sterilization processes. Functional/performance testing and biocompatibility testing confirmed that reprocessed devices perform as intended and are safe and effective.

Technological Characteristics

Non-woven fabric garments with hook-and-loop fasteners; integrated air bladders, hoses, and connectors. Sterilized via ethylene oxide to 10^-6 sterility assurance level. No changes to OEM specifications. Mechanical operation via external pneumatic pump.

Indications for Use

Indicated for high-risk and/or non-ambulatory patients requiring prophylaxis against deep vein thrombosis (DVT) or pulmonary embolism (PE). Prescription use only; single patient use.

Regulatory Classification

Identification

A compressible limb sleeve is a device that is used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ OCT 1 7 2001 : K012403 Page 1 of 3 ### 510(k) Summary of Safety & Effectiveness | Submitter | Vanguard Medical Concepts, Inc.<br>5307 Great Oak Drive<br>Lakeland, FL 33815 | |-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Contact | Mr. Michael Sammon, Ph.D.<br>Director, Engineering<br>(863) 683-8680, extension 228<br>mikes@safe-reuse.com | | Date | May 31, 2001 | | Devices | <ul><li>Trade Names: Vanguard Reprocessed Compression Garments <ul><li>⇒ Kendall SCD™ Sequential Compression Sleeves</li><li>⇒ Kendall ImPad™ Rigid Sole Foot Covers</li><li>⇒ Huntleigh Healthcare DVT Garments</li><li>⇒ Aircast® VenaFlow® Cuffs</li><li>⇒ Nutech®PlexiPulse® Wraps</li><li>⇒ Healthcare Service &amp; Supply ALP® Alternating Leg Pressure® Garments</li></ul></li><li>Common Name: Compression garment, Compressible Limb Sleeve</li><li>Classification: 21 CFR 870.5800 – Compressible Limb Sleeve – Class II</li><li>Product Code JOW</li></ul> | | Predicate Devices | <ul><li>Kendall SCD™ Sequential Compression Sleeves and ImPad™ Rigid Sole Foot Covers believed to be legally marketed under various possible 510(k) premarket notifications (K781357, K863581, K890938, K932835, K942664, K992079)</li><li>Huntleigh Healthcare DVT Garments believed to be legally marketed under a couple of possible 510(k) premarket notifications (K881632, K961166)</li><li>Aircast® VenaFlow® Cuffs believed to be legally marketed under the possible 510(k) premarket notification K932900</li><li>Nutech®PlexiPulse® Wraps believed to be legally marketed under a couple of possible 510(k) premarket notifications (K944567, K981311)</li></ul> | | | Continued on next page | {1}------------------------------------------------ K012403 Взегуз # 510(k) Summary of Safety & Effectiveness, Continued | Predicate Devices, continued | Healthcare Service & Supply ALP® Alternating Leg Pressure® Garments believed to be legally marketed under various possible 510(k) premarket notifications (K955853, K964188, K974318, K000303) | |------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Indications for Use | When coupled with an appropriate inflation system, compression garments are intended to increase venous return from the legs and feet as a prophylaxis for the formation of deep vein thrombosis (DVT) or subsequent pulmonary embolism (PE) in high risk and/or non-ambulatory patients. The compression garments are prescription devices intended for a single patient use only. | | Device Description | Compressible limb sleeves are devices that are used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb and increasing venous flow. Compression therapy is generally prescribed as a prophylaxis for deep vein thrombosis (DVT). The compression system consists of two primary pieces: an air compression pump and a soft, flexible sleeve in which the patient's extremity is placed. A hose to the pump connects to the sleeve, and when the pump is turned on, the air inflates the sleeve, applying a gentle pressure to the patient's extremity.<br>Compression garments consist of a non-woven fabric with “hook and loop” fasteners for attaching around the foot or leg. Air cells within the garment are molded to plastic hoses with connectors for attachment to the pump. The hoses and connectors are non-detachable and are reprocessed as part of the garment. Depending upon the original equipment manufacturer (OEM), garments may contain a single bladder and hose or multiple compartments and hoses that are sequentially pressurized.<br>Vanguard receives previously used compression garments from healthcare facilities; cleans, inspects, tests, repackages and sterilizes the garments; and returns them to the healthcare facility.<br>Continued on next page | {2}------------------------------------------------ K 012403 Page 3 of 3 # 510(k) Summary of Safety & Effectiveness, Continued | Technological<br>Characteristics | The Vanguard reprocessed compression garments are essentially identical to the currently marketed OEM compression garments. No changes are made to the currently marketed devices' specifications (with the exception of sterility) and they possess the same technological characteristics. The OEM devices are marketed as non-sterile. As requested by customers, the Vanguard reprocessed devices are sterilized. Ethylene oxide gas is utilized and the sterilization validation demonstrates that sterility is achieved to a 10 <sup>-6</sup> assurance level. Post-sterilization biocompatibility and performance/functional testing also demonstrate that the devices continue to be safe and effective for their intended use. | |----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Test Data | Decontamination and cleaning, packaging and sterilization validations and functional/performance and biocompatibility testing demonstrates that the reprocessed devices perform as intended and are safe and effective. | | Conclusion | Based on the information provided herein and the 510(k) "Substantial Equivalence" Decision Making Process Chart, we conclude that the Vanguard reprocessed compression garments are substantially equivalent to the predicate devices, the respective OEM compression garments under the Federal Food, Drug and Cosmetic Act. | {3}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/3/Picture/2 description: The image is a black and white circular logo. The logo features a stylized image of an eagle with its wings spread, and the silhouette of two human faces in profile. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper perimeter of the circle. OCT 1 7 2001 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Michael Sammon, Ph.D. Director, Engineering Vanguard Medical Concepts, Inc. 5307 Great Oaks Drive Lakeland, FL 33815 Re: K012403 Trade Name: Vanguard Reprocessed Compression Garment Regulation Number: 21 CFR 870.5800 Regulation Name: Compressible Limb Sleeve Regulatory Class: Class II (two) Product Code: JOW Dated: May 31, 2001 Received: July 30, 2001 Dear Dr. Sammon: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for the barresor to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ Page 2 - Michael Sammon, Ph.D. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, K. Dillard III James E. Dillard III Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ K012403 #### Indications for Use 510(k) Number: Kol2403 Device Name: Vanguard Reprocessed Compression Garments Indications for Use: When coupled with an appropriate inflation system, compression garments are intended to When coupled with an appropriate innution of sea prophylaxis for the formation of deep vein increase venous relum from the legs and leve a proprifican high risk and/or non-ambulatory thromboss (DV I ) of Subscquent pumblical ( encommand ( = ) patients. The compression garments are prescription devices intended for a single patient use only. #### (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED.) IF NEEDED.) ------------------------------------------------------------------------------------------------------------------------------------------------------------------ Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use_ (Per 21 CFR 801.109) : . OR Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (Optional Format 1-2-96) kh ``` Division of Cardiovascular & Respiratory Devices of Cardiovascular & Respi 510(k) Number K02403 iv
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...